Patents Assigned to NATIONAL UNIVERSITY CO., HAMAMATSU UNIVER. SCHOOL OF MEDICINE
  • IMMUNOPOTENTIATING AGENT COMPRISING EP1 AGONIST
    Publication number: 20110038884
    Abstract: An EP1 agonist has an immunopotentiating effect mediated by cytotoxic T lymphocyte activation and/or natural killer cell activation, and is thus useful for the prevention and/or treatment of cancers, microbial infectious diseases and the like.
    Type: Application
    Filed: April 27, 2009
    Publication date: February 17, 2011
    Applicant: NATIONAL UNIVERSITY CO., HAMAMATSU UNIVER. SCHOOL OF MEDICINE
    Inventors: Masahiro Takigawa, Naohiro Seo, Takayuki Maruyama, Toshiya Kanaji